High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS
Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Neisseria adhesin A (NadA), and outer membrane vesic...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-09-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.1904758 |
| _version_ | 1827807667041599488 |
|---|---|
| author | Sarah J. Tozer Helen V. Smith David M. Whiley Ray Borrow Giuseppe Boccadifuoco Duccio Medini Davide Serruto Marzia Monica Giuliani Maria Stella Rosita De Paola Alessandro Muzzi Mariagrazia Pizza Theo P. Sloots Michael D. Nissen |
| author_facet | Sarah J. Tozer Helen V. Smith David M. Whiley Ray Borrow Giuseppe Boccadifuoco Duccio Medini Davide Serruto Marzia Monica Giuliani Maria Stella Rosita De Paola Alessandro Muzzi Mariagrazia Pizza Theo P. Sloots Michael D. Nissen |
| author_sort | Sarah J. Tozer |
| collection | DOAJ |
| description | Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Neisseria adhesin A (NadA), and outer membrane vesicles of the New Zealand strain with Porin 1.4. A meningococcal antigen typing system (MATS) and a fully genomic approach, genetic MATS (gMATS), were developed to predict coverage of MenB strains by 4CMenB. We characterized 520 MenB invasive disease isolates collected over a 5-year period (January 2007–December 2011) from all Australian states/territories by multilocus sequence typing and estimated strain coverage by 4CMenB. The clonal complexes most frequently identified were ST-41/44 CC/Lineage 3 (39.4%) and ST-32 CC/ET-5 CC (23.7%). The overall MATS predicted coverage was 74.6% (95% coverage interval: 61.1%–85.6%). The overall gMATS prediction was 81.0% (lower–upper limit: 75.0–86.9%), showing 91.5% accuracy compared with MATS. Overall, 23.7% and 13.1% (MATS) and 26.0% and 14.0% (gMATS) of isolates were covered by at least 2 and 3 vaccine antigens, respectively, with fHbp and NHBA contributing the most to coverage. When stratified by year of isolate collection, state/territory and age group, MATS and gMATS strain coverage predictions were consistent across all strata. The high coverage predicted by MATS and gMATS indicates that 4CMenB vaccination may have an impact on the burden of MenB-caused IMD in Australia. gMATS can be used in the future to monitor variations in 4CMenB strain coverage over time and geographical areas even for non-culture confirmed IMD cases. |
| first_indexed | 2024-03-11T22:00:38Z |
| format | Article |
| id | doaj.art-6a72f64bde4941cd97e2199d0797ffb5 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:00:38Z |
| publishDate | 2021-09-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-6a72f64bde4941cd97e2199d0797ffb52023-09-25T11:17:06ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-09-011793230323810.1080/21645515.2021.19047581904758High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATSSarah J. Tozer0Helen V. Smith1David M. Whiley2Ray Borrow3Giuseppe Boccadifuoco4Duccio Medini5Davide Serruto6Marzia Monica Giuliani7Maria Stella8Rosita De Paola9Alessandro Muzzi10Mariagrazia Pizza11Theo P. Sloots12Michael D. Nissen13Queensland Children’s HospitalForensic & Scientific ServicesQueensland Children’s HospitalManchester Royal InfirmaryGSKGSKGSKGSKGSKGSKGSKGSKQueensland Children’s HospitalQueensland Children’s HospitalMeningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA), Neisseria adhesin A (NadA), and outer membrane vesicles of the New Zealand strain with Porin 1.4. A meningococcal antigen typing system (MATS) and a fully genomic approach, genetic MATS (gMATS), were developed to predict coverage of MenB strains by 4CMenB. We characterized 520 MenB invasive disease isolates collected over a 5-year period (January 2007–December 2011) from all Australian states/territories by multilocus sequence typing and estimated strain coverage by 4CMenB. The clonal complexes most frequently identified were ST-41/44 CC/Lineage 3 (39.4%) and ST-32 CC/ET-5 CC (23.7%). The overall MATS predicted coverage was 74.6% (95% coverage interval: 61.1%–85.6%). The overall gMATS prediction was 81.0% (lower–upper limit: 75.0–86.9%), showing 91.5% accuracy compared with MATS. Overall, 23.7% and 13.1% (MATS) and 26.0% and 14.0% (gMATS) of isolates were covered by at least 2 and 3 vaccine antigens, respectively, with fHbp and NHBA contributing the most to coverage. When stratified by year of isolate collection, state/territory and age group, MATS and gMATS strain coverage predictions were consistent across all strata. The high coverage predicted by MATS and gMATS indicates that 4CMenB vaccination may have an impact on the burden of MenB-caused IMD in Australia. gMATS can be used in the future to monitor variations in 4CMenB strain coverage over time and geographical areas even for non-culture confirmed IMD cases.http://dx.doi.org/10.1080/21645515.2021.1904758meningococcal serogroup b4cmenbmatsgmatsstrain coverageaustralia |
| spellingShingle | Sarah J. Tozer Helen V. Smith David M. Whiley Ray Borrow Giuseppe Boccadifuoco Duccio Medini Davide Serruto Marzia Monica Giuliani Maria Stella Rosita De Paola Alessandro Muzzi Mariagrazia Pizza Theo P. Sloots Michael D. Nissen High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS Human Vaccines & Immunotherapeutics meningococcal serogroup b 4cmenb mats gmats strain coverage australia |
| title | High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS |
| title_full | High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS |
| title_fullStr | High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS |
| title_full_unstemmed | High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS |
| title_short | High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007–2011: Concordant predictions between MATS and genetic MATS |
| title_sort | high coverage of diverse invasive meningococcal serogroup b strains by the 4 component vaccine 4cmenb in australia 2007 2011 concordant predictions between mats and genetic mats |
| topic | meningococcal serogroup b 4cmenb mats gmats strain coverage australia |
| url | http://dx.doi.org/10.1080/21645515.2021.1904758 |
| work_keys_str_mv | AT sarahjtozer highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT helenvsmith highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT davidmwhiley highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT rayborrow highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT giuseppeboccadifuoco highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT ducciomedini highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT davideserruto highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT marziamonicagiuliani highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT mariastella highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT rositadepaola highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT alessandromuzzi highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT mariagraziapizza highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT theopsloots highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats AT michaeldnissen highcoverageofdiverseinvasivemeningococcalserogroupbstrainsbythe4componentvaccine4cmenbinaustralia20072011concordantpredictionsbetweenmatsandgeneticmats |